Temple Lung Center at ATS 2026: Conference Recap
The American Thoracic Society's 2026 International Conference brought together leading voices in pulmonary, critical care, and sleep medicine — and Temple Health was well represented.
Clinical Scorecard: Temple Lung Center at ATS 2026: Conference Recap
At a Glance
Category Detail
Condition Chronic Obstructive Pulmonary Disease (COPD) and related pulmonary conditions Key Mechanisms Emerging therapies and diagnostic strategies in pulmonary medicine Target Population Patients with COPD, interstitial lung disease, and pulmonary hypertension Care Setting Pulmonary, critical care, and sleep medicine
Key Highlights
Pooled results indicate mepolizumab reduces COPD exacerbations requiring hospitalization. Elevated eosinophil counts near conception predict asthma exacerbations during pregnancy. Inhaled treprostinil significantly preserves lung function in adults with idiopathic pulmonary fibrosis. Higher corticosteroid doses associated with shorter hospitalization in AE-SARD-ILD survivors. Pre-procedural CT analysis identifies risk factors for pneumothorax after bronchoscopic lung volume reduction. Guideline-Based Recommendations
Diagnosis
Consider eosinophil counts for predicting asthma exacerbations during pregnancy. Management
Mepolizumab as an add-on therapy for COPD patients with elevated eosinophil counts. Monitoring & Follow-up
Utilize 6-minute walk testing to predict exacerbations in COPD patients. Risks
Identify disparities in access and survival rates in SARD-ILD patients. Patient & Prescribing Data
Patients with COPD, interstitial lung disease, and pulmonary hypertension
Sotatercept shows potential in improving clinical outcomes in Group 3 pulmonary hypertension.
Clinical Best Practices
Monitor inflammatory biomarkers in COPD exacerbations. Evaluate lung function preservation strategies in IPF patients. Related Resources & Content
